Synlett 2010(12): 1854-1858  
DOI: 10.1055/s-0030-1258113
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

One-Pot Synthesis of α-Alkylidene-γ-butyrolacton-2-ones (Tetronic Acid Derivatives): Polar Solvent Induces a New Type of γ-Lactonization

Abdolali Alizadeh*, Hamideh Sabahnoo, Zohreh Noaparast, Nasrin Zohreh, Azadeh Mikaeili
Department of Chemistry, Tarbiat Modares University, P.O. Box 14115-175, Tehran, Iran
Fax: +98(21)88006544; e-Mail: aalizadeh@modares.ac.ir;
Further Information

Publication History

Received 19 March 2010
Publication Date:
30 June 2010 (online)

Abstract

An efficient, one-pot synthetic protocol toward α-alkylidene-γ-butyrolacton-2-ones, a rather unexplored class of heterocyclic scaffolds starting from primary amines, methyl acetoacetate, and chloroacetyl chloride is described. The mixture of MeCN-MeOH as a polar solvent triggers a new cycloaddition of the enaminone intermediate. The reaction is completed within 12 hours under reflux condition to produce the title compounds.

    References and Notes

  • 1 Raphael RA. Ravenscroft P. J. Chem. Soc., Perkin Trans. 1  1988,  1823 
  • 2 Dueholm KL. Pederson LB. Synthesis  1992,  1 
  • 3 Robertson DW. Krushinski JH. Utterback BG. Kauffman RF. J. Med. Chem.  1989,  32:  1476 
  • 4 Bjeldanes LF. J. Org. Chem.  1977,  42:  2333 
  • 5 Weidner-Wells MA. Decamp A. Mazzocchi PH.
    J. Org. Chem.  1989,  54:  5746 
  • 6 Von Hoffman HMR. Rabe J. Angew. Chem., Int. Ed. Engl.  1985,  97:  94 
  • 7 Rücker G. Gajewski W. J. Med. Chem.  1985,  20:  87 
  • 8 Streibl M. Nawrot J. Herout V. Biochem. Syst. Ecol.  1983,  11:  381 
  • 9 Ley SV. Toogood PL. Chem. Brit.  1990,  31 
  • 10 Paruch E. Wiadomosci Chemiczne  2001,  55:  93 
  • 11a Moise J. Arseniyadis S. Cossy J. Org. Lett.  2007,  9:  1695 
  • 11b Raju R. Allen L. Le T. Taylor C. Howell A. Org. Lett.  2007,  9:  1699 
  • 11c Oh S. Jeong IH. Shin WS. Wang Q. Lee S. Bioorg. Med. Chem. Lett.  2006,  16:  1656 
  • 12a Janecki T. Blaszczyk E. Janecka A. Krajewaska U. Rozalski M. J. Med. Chem.  2005,  48:  3516 
  • 12b Huang WC. Chan ST. Yang TL. Tzeng CC. Chen CC. Carcinogenesis  2004,  25:  1925 
  • 13a De Bernardi M. Garlaschelli L. Toma L. Vidari G. Vita-Finzi P. Tetrahedron  1991,  47:  7109 
  • 13b Vidari G. Lanfranchi G. Pazzi N. Serra S. Tetrahedron Lett.  1999,  40:  3063 
  • 13c Jung M. Lee S. Yoon B. Tetrahedron Lett.  1997,  38:  2871 
  • 13d Tesaki S. Kikuzaki H. Yonemori S. Nakatani N. J. Nat. Prod.  2001,  64:  515 
  • 14a De D. Seth M. Bhaduri AP. Synthesis  1990,  956 
  • 14b Ohta T. Miyake T. Seido N. Kumobayashi H. Takaya H. J. Org. Chem.  1995,  60:  357 
  • 14c Arcadi A. Chiarini M. Marinelli F. Berente Z. Kollàr L. Org. Lett.  2000,  2:  69 
  • 15 Otto A. Liebscher J. Synthesis  2003,  1209 
  • 16 Gasperi T. Loreto MA. Tardella PA. Veri E. Tetrahedron Lett.  2003,  44:  4953 
  • 17a Castulík J. Marek J. Mazal C. Tetrahedron  2001,  57:  8339 
  • 17b Otto A. Ziemer B. Liebscher J. Synthesis  1999,  965 
  • 18a Otto A. Ziemer B. Liebscher J. Eur. J. Org. Chem.  1998,  2667 
  • 18b Otto A. Abegaz B. Ziemer B. Liebscher J. Tetrahedron: Asymmetry  1999,  10:  3381 
  • 18c Nishimura K. Tomioka K. J. Org. Chem.  2002,  67:  431 
  • 19 Read de Alaniz J. Rovis T. J. Am. Chem. Soc.  2005,  127:  6284 
  • 20a Neelakantan S. Seshadri TR. Current Sci. (India)  1959,  28:  476 
  • 20b Haynes LJ. Plimmer JR. Quart. Rev.  1960,  14:  292 
  • 20c Brodersen R. Kjaer A. Acta Pharmacol. Toxicol.  1946,  2:  109 
  • 21a Effenberger F. Syed J. Tetrahedron: Asymmetry  1998,  9:  817 
  • 21b Bühler H. Bayer A. Effenberger F. Chem. Eur. J.  2000,  6:  2564 
  • 22 Kasettrathat C. Ngamrojanavanich N. Wiyakrutta S. Mahidol C. Ruchirawat S. Kittakoop P. Phytochemistry  2008,  69:  2621 
  • 23a Schobert R. Schlenk A. Bioorg. Med. Chem.  2008,  16:  4203 
  • 23b Pevet I. Meyer C. Cossy J. Tetrahedron Lett.  2001,  42:  5215 
  • 23c Bourdreux Y. Bodio E. Willis C. Billaud C. Gall T. Mioskowski C. Tetrahedron  2008,  64:  8930 
  • 23d Mitsos CA. Zografos AL. Igglessi-Markopoulou O. J. Org. Chem.  2000,  65:  5852 
  • 23e Sodeoka M. Sampe R. Kojima S. Baba Y. Usui T. Ueda K. Osada H. J. Med. Chem.  2001,  44:  3216 
  • 23f Peukert S. Sun Y. Zhang R. Hurley B. Sabio M. Shen X. Gray C. Dzink-Fox J. Tao J. Cebula R. Wattanasin S. Bioorg. Med. Chem. Lett.  2008,  18:  1840 
  • 23g Schobert R. Urbina-Gonzalez JM. Tetrahedron Lett.  2005,  46:  3657 
  • 24a Ramachandran P. Garner G. Pratihar D. J. Org. Lett.  2007,  9:  4753 
  • 24b Moïse J. Arseniyadis S. Cossy J. Org. Lett.  2007,  9:  1695 
  • 24c Seitz M. Reiser O. Curr. Opin. Chem. Biol.  2005,  9:  285 
  • 24d Yavari I. Hossaini Z. Tetrahedron Lett.  2006,  47:  4465 
  • 24e Zhang Q. Lu X. Han X. J. Org. Chem.  2001,  66:  7676 
  • 24f Kitson RRA. Taylor RJK. Wood JL. Org. Lett.  2009,  11:  5338 
  • 24g Ramachandran PV. Pratiharorg D. Org. Lett.  2007,  9:  2087 
  • 24h Moise J. Arseniyadis S. Cossy J. Org. Lett.  2007,  9:  1695 
  • 24i Ramachandran PV. Garner G. Pratihar D. Org. Lett.  2007,  9:  4753 
  • 25a Alizadeh A. Movahedi F. Esmaili AA. Tetrahedron Lett.  2006,  47:  4469 
  • 25b Alizadeh A. Movahedi F. Masrour H. Zhu LG. Synthesis  2006,  3431 
  • 25c Alizadeh A. Rezvanian A. Zhu LG. Tetrahedron  2008,  64:  351 
  • 25d Alizadeh A. Rezvanian A. Bijanzadeh HR. Synthesis  2008,  725 
  • 25e Alizadeh A. Babaki M. Zohreh N. Tetrahedron  2009,  65:  1704 
  • 25f Alizadeh A. Babaki M. Zohreh N. Synthesis  2008,  3295 
26

To a magnetically stirred 10 mL flat-bottom flask, containing ethylamine (0.09 g, 2 mmol) was added methyl acetoacetate (0.24 g, 2 mmol), and this mixture was stirred at r.t. under solvent-free conditions for 10 min. A solution of chloroacetyl chloride (0.22 g, 2 mmol) in MeCN (5 mL) was added dropwise to the reaction mixture. The progress of the reaction was followed by TLC. When enaminone 5 was fully consumed, MeOH (2 mL) was added and the mixture allowed to stir at 110-120 ˚C for 11 h. After completion of the reaction, the solvent was removed under reduced pressure. The residue was purified by column chromatog-raphy on silica gel (n-hexane-EtOAc = 1:1) to obtain product 4a as a white powder (0.12 g, 71%). IR (KBr): 3460 (NH), 1728 (CO2), 1638 (C=O), 1615 (C=C) cm. MS (EI, 70 eV): m/z (%) = 169 (93) [M+], 151 (85), 123 (38), 95 (34), 82 (69), 68 (50), 58 (100), 42 (92). E-Isomer of 4a: ¹H NMR (500.13 MHz, CDCl3): δ = 1.35 (3 H, t, ³ J H,H = 7.3 Hz, CH2CH 3), 2.54 (3 H, s, CH3), 3.47 (2 H, q, ³ J H,H = 7.3 Hz, CH 2CH3), 4.40 (2 H, s, CH2O), 10.99 (1 H, s, NH). ¹³C NMR (125.75 MHz, CDCl3): δ = 13.86 (CH2 CH3), 14.42 (CH3), 38.43 (CH2CH3), 69.97 (OCH2), 91.76 (C=CCH3), 170.80 (C=CCH3), 172.52 (CO2), 197.10 (C=O).
Z-isomer of 4a: ¹H NMR (500.13 MHz, CDCl3): δ = 1.32 (3 H, t, ³ J H,H = 7.3 Hz, CH2CH 3), 2.58 (3 H, s, CH3), 3.50 (2 H, q, ³ J H,H = 7.3 Hz, CH 2CH3), 4.38 (2 H, s, CH2O), 10.01 (1 H, s, NH). ¹³C NMR (125.75 MHz, CDCl3): δ = 14.27 (CH2 CH3), 14.62 (CH3), 38.12 (CH2CH3), 72.00 (OCH2), 90.36 (C=CCH3), 169.94 (C=CCH3), 176.35 (CO2), 193.62 (C=O).
Compound 4b: yield 0.28 g (80%); white powder; mp 112-114 ˚C. IR (KBr): 3465 (NH), 1734 (CO2), 1661 (C=O), 1604 (C=C) cm. MS (EI, 70 eV): m/z (%) = 183 (100) [M+], 165 (87), 154 (70), 150 (59), 137 (39), 125 (47), 97 (75), 82 (72), 67 (70).
E-isomer of 4b: ¹H NMR (500.13 MHz, CDCl3): δ = 1.05 (3 H, t, ³ J H,H = 7.4 Hz, CH2CH 3), 1.75 (2 H, q, ³ J H,H = 7.4 Hz, CH 2CH3), 2.55 (3 H, s, CH3), 3.43 (2 H, t, ³ J H,H = 6.9 Hz, CH2N), 4.42 (2 H, s, OCH2), 11.10 (1 H, s, NH). ¹³C NMR (125.75 MHz, CDCl3): δ = 11.16 (CH2 CH3), 13.96 (CH3), 30.87 (CH2CH3), 45.18 (CH2N), 69.97 (CH2O), 91.88 (C=CCH3), 161.90 (C=CCH3), 170.96 (CO2), 197.18 (C=O).
Z-isomer of 4b: ¹H NMR (500.13 MHz, CDCl3): δ = 1.03 (3 H, t, ³ J H,H = 7.4 Hz, CH2CH 3), 1.72 (2 H, q, ³ J H,H = 7.4 Hz, CH 2CH3), 2.60 (3 H, s, CH3), 3.40 (2 H, t, ³ J H,H = 7.0 Hz, CH2N), 4.40 (2 H, s, OCH2), 10.13 (1 H, s, NH). ¹³C NMR (125.75 MHz, CDCl3): δ = 11.16 (CH2 CH3), 14.37 (CH3), 31.22 (CH2CH3), 44.85 (CH2N), 72.04 (CH2O), 90.44 (C=CCH3), 161.93 (C=CCH3), 170.07 (CO2), 193.61 (C=O).
Compound 4e: yield 0.28 g (82%); white powder; mp 118-120 ˚C. IR (KBr): 3230 (NH), 1725 (CO2), 1639 (C=O), 1604 (C=C) cm. MS (EI, 70 eV): m/z (%) = 183 (100) [M+], 165 (78), 137 (24), 110 (39), 96 (94), 83 (47), 67 (35), 55 (16).
E-isomer of 4e: ¹H NMR (500.13 MHz, CDCl3): δ = 1.30 (6 H, d, ³ J H,H = 6.2 Hz, 2 CHCH 3), 2.51 (3 H, s, CH3), 3.91-3.99 (1 H, m, 1 CHCH3), 4.33 (2 H, s, CH2O), 10.94 (1 H, s, NH). ¹³C NMR (125.75 MHz, CDCl3): δ = 13.85 (2 CHCH3), 22.82 (CH3), 45.75 (CHCH3), 69.89 (CH2O), 91.43 (C=CCH3), 169.43 (C=CCH3), 172.53 (CO2), 196.96 (C=O).
Z-isomer of 4e: ¹H NMR (500.13 MHz, CDCl3): δ = 1.28 (6 H, d, ³ J H,H = 6.2 Hz, 2 CHCH 3), 2.56 (3 H, s, CH3), 3.91-3.99 (1 H, m, CHCH3), 4.30 (2 H, s, CH2O), 9.94 (1 H, s, NH). ¹³C NMR (125.75 MHz, CDCl3): δ = 14.31 (2 CHCH3), 22.78 (CH3), 45.41 (CHCH3), 71.84 (CH2O), 90.05 (C=CCH3), 168.61 (C=CCH3), 176.31 (CO2), 193.58 (C=O).